FDA-Inspected Site

US Specialty Formulations LLC

8 FDA inspections are on record for US Specialty Formulations LLC in Allentown, United States.

483· Form 483 issued

Allentown, United States · Last updated July 9, 2026

Overview

  • 8 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-01-14.

At a glance

Inspections

8

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
5 Jan 2026 – 14 Jan 2026Human Drugs483View 483 →
19 Mar 2025 – 26 Mar 2025Human Drugs483View 483 →
17 Jun 2024 – 2 Jul 2024Human Drugs483On file
21 Mar 2022 – 26 Apr 2022Human DrugsWLView 483 →
18 Jun 2019 – 23 Jul 2019Human Drugs483View 483 →
9 Aug 2017 – 29 Aug 2017Human Drugs483View 483 →
11 May 2015 – 29 May 2015Human DrugsWLView 483 →
17 Mar 2014 – 18 Mar 2014Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

14 Jan 2026
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.165(e)

Test methods

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.166(a)

Lack of written stability program

Cited by Mindy M Chou, Lu Chen

14 Jan 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Mindy M Chou, Lu Chen

Investigators

FDA investigators tied to this site in the record.

Lu Chen2 insp.
Nabihah Amatullah1 insp.
Lori M Newman1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations5x
21 CFR 211.165(a)Cited across public-safe Form 483 observations4x
21 CFR 211.28(a)Cited across public-safe Form 483 observations4x
21 CFR 211.100(a)Cited across public-safe Form 483 observations3x
21 CFR 211.165(e)Cited across public-safe Form 483 observations3x
21 CFR 211.192Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations3x
FDCA 503B(a)(10)Cited across public-safe Form 483 observations3x
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.42(a)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations2x
21 CFR 211.67(a)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.111Cited across public-safe Form 483 observations1x
21 CFR 211.115(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(c)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.167(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.94(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind US Specialty Formulations LLC's 7 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat